Journal
MOLECULES
Volume 18, Issue 9, Pages 10953-10972Publisher
MDPI
DOI: 10.3390/molecules180910953
Keywords
P2X7R; inflammatory response; antagonists and pharmacological target
Funding
- FAPERJ
- CNPq
- PAPES V/Fiocruz-CNPq
- Oswaldo Cruz Institute
Ask authors/readers for more resources
The P2X7 receptor (P2X7R) is a nonselective cation channel that is activated by extracellular ATP and triggers the secretion of several proinflammatory substances, such as IL-1 beta, IL-18, TNF-alpha, and nitric oxide. Recently, several preclinical studies have demonstrated that this receptor participates in inflammation and pain mechanisms. Taken together, these results indicate that P2X7R is a promising pharmacological target, and compounds that modulate the function of this receptor show potential as new anti-inflammatory medicines. In this review, we discuss aspects of P2X7R pharmacology and the participation of this protein in inflammation and pain and provide an overview of some promising compounds that have been tested as antagonists of P2X7R, with clinical applicability.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available